APA

Breitz H. B., Weiden P. L., Vanderheyden J. L., Appelbaum J. W., Bjorn M. J., Fer M. F., Wolf S. B., Ratliff B. A., Seiler C. A. & Foisie D. C. (19920706). Clinical experience with rhenium-186-labeled monoclonal antibodies for radioimmunotherapy: results of phase I trials. : Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Chicago

Breitz H B, Weiden P L, Vanderheyden J L, Appelbaum J W, Bjorn M J, Fer M F, Wolf S B, Ratliff B A, Seiler C A and Foisie D C. 19920706. Clinical experience with rhenium-186-labeled monoclonal antibodies for radioimmunotherapy: results of phase I trials. : Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Harvard

Breitz H. B., Weiden P. L., Vanderheyden J. L., Appelbaum J. W., Bjorn M. J., Fer M. F., Wolf S. B., Ratliff B. A., Seiler C. A. and Foisie D. C. (19920706). Clinical experience with rhenium-186-labeled monoclonal antibodies for radioimmunotherapy: results of phase I trials. : Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

MLA

Breitz H B, Weiden P L, Vanderheyden J L, Appelbaum J W, Bjorn M J, Fer M F, Wolf S B, Ratliff B A, Seiler C A and Foisie D C. Clinical experience with rhenium-186-labeled monoclonal antibodies for radioimmunotherapy: results of phase I trials. : Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 19920706.